TNDM — TANDEM DIABETES CARE INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1438133 ·
Last close
$16.11
Market Cap
$1.12B
52W High
$29.65
52W Low
$12.26
ADV30
2,054,221
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 254,560,000 | 144,780,000 | -13,792,000 | -21,168,000 | 1,154,202,000 | 62,818,000 | 1,023,814,000 |
| Mar 2026 | 247,221,000 | 136,788,000 | -17,434,000 | -20,393,000 | 1,153,394,000 | 179,325,000 | 1,020,991,000 |
| Dec 2025 | 290,383,000 | 167,460,000 | 8,294,000 | -589,000 | 881,112,000 | 90,634,000 | 725,942,000 |
| Sep 2025 | 249,253,000 | 134,292,000 | -22,863,000 | -21,165,000 | 874,653,000 | 91,947,000 | 741,688,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,523,000
Investing CF
$-277,224,000
Financing CF
$277,349,000
CapEx
$-56,219,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.93
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,294,096,000
Inventory
$135,106,000
Receivables
$162,065,000
ST Investments
$393,178,000
EBIT TTM
$-54,638,000
Pretax Income TTM
$-60,996,000
Interest Exp TTM
$6,358,000
Analysts
20
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,041,417,024
EBITDA
$-25,033,000
Free Cash Flow
$-43,949,124
Enterprise Value
$1,473,748,736
Total Cash
$455,996,000
Total Debt
$739,252,992
Shares Out
69,578,707
Trailing EPS
$-0.90
Book Value
$1.88
ROE
-48.0%
ROA
-2.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,014,736,000 | -167,306,000 | -204,710,000 | 881,112,000 | 725,942,000 | 155,170,000 | -9,721,000 |
| Dec 2024 | 940,203,000 | -99,127,000 | -96,025,000 | 967,658,000 | 704,560,000 | 263,098,000 | 24,225,000 |
| Dec 2023 | 747,718,000 | -233,230,000 | -222,611,000 | 952,658,000 | 639,026,000 | 313,632,000 | -31,810,000 |
| Dec 2022 | 801,217,000 | -92,848,000 | -94,594,000 | 1,052,785,000 | 612,838,000 | 439,947,000 | 50,464,000 |
TTM Snapshot
Revenues TTM
$1,027,535,000
NetIncome TTM
$-94,547,000
OpCashFlow TTM
—
Assets (Latest)
$1,153,394,000
Forward EPS
$0.17
Max Pain — expiry 2027-01-15
max pain strike: $15.00 · spot: $16.11 · call oi: 3,092 · put oi: 2,718
Expected Move to 2027-01-15:
±$4.27
(26.51%) —
implied range
$11.84 –
$20.38
· ATM straddle on $16.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IRMD | IRADIMED CORP | $1.12B | $87.45 | — |
| CDRE | Cadre Holdings, Inc. | $1.05B | $24.55 | — |
| PRCT | PROCEPT BioRobotics Corp | $1.05B | $18.40 | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.05B | $13.44 | — |
| AORT | ARTIVION, INC. | $1.04B | $21.26 | — |
News headlines (Yahoo Finance, 1h cache)
Is it the Right Time to Hold TNDM Stock in Your Portfolio?
2026-10-09 13:05 · Yahoo
Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System
2026-10-01 01:22 · Yahoo
Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks
2026-09-30 20:29 · Yahoo
Is Tandem Diabetes Care (TNDM) Undervalued As Investors Weigh Its 34% One Year Return?
2026-09-20 09:10 · Yahoo
Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock?
2026-09-17 09:34 · Yahoo
Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now
2026-09-09 18:38 · Yahoo
Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi
2026-08-18 06:02 · Yahoo
5 Must-Read Analyst Questions From Tandem Diabetes’s Q2 Earnings Call
2026-08-15 04:45 · Yahoo
Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript
2026-08-14 01:17 · Yahoo
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets
2026-09-28 07:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.